Interestingly, our findings revealed that treating AML cells with MSC-exosomes reduced the expression of JAK2 in AML cells, suggesting that BM-MSCs may obstruct JAK2 expression and activation in AML through exosome secretion. The gene discussed is JAK2; the disease is acute myeloid leukemia.